Contego Medical

Contego Medical

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $60M

Overview

Contego Medical is a private, commercial-stage medical device company founded in 2016 and headquartered in Raleigh, North Carolina, USA. The company specializes in developing advanced, integrated devices for embolic protection and thrombectomy during vascular interventions, aiming to streamline complex procedures. Its marketed product portfolio includes the Neuroguard IEP and Vanguard IEP systems for integrated embolic protection and the Excipio thrombectomy system. Contego is positioned in the large and growing market for minimally invasive treatments for carotid and peripheral artery disease.

CardiovascularPeripheral Vascular DiseaseCarotid Artery Disease

Technology Platform

Integrated Embolic Protection (IEP) platform combining therapeutic devices (e.g., stent delivery systems) with embolic protection filters into single, multi-functional systems to simplify procedures and improve safety.

Funding History

3
Total raised:$60M
Series B$40M
Series A$15M
Seed$5M

Opportunities

The large and growing market for minimally invasive treatments for carotid and peripheral artery disease presents a significant opportunity.
An aging population and increasing prevalence of diabetes drive demand.
The company's integrated device approach targets key hospital needs for procedural efficiency and cost reduction.

Risk Factors

Faces intense competition from large, established medical device companies with greater resources and sales reach.
Clinical adoption of new techniques by physicians can be slow.
Regulatory hurdles and securing favorable insurance reimbursement are ongoing challenges.

Competitive Landscape

Operates in the highly competitive vascular intervention space, competing directly with major players like Boston Scientific, Medtronic, Abbott, and Philips. These competitors offer standalone embolic protection devices, stents, and thrombectomy systems. Contego's differentiation is the integration of these functions into single platforms.